Table 2: New cases and age-standardized incidence rates (ASIR) of cancer in children aged 0 to 14 years by sex, 2001-2006, Canada (English, CSV)

Table 2: New cases and age-standardized incidence rates (ASIR) of cancer in children aged 0 to 14 years by sex, 2001-2006, Canada: English CSV file you can open as a table, filter, chart and export up to 10,000 rows. From Public Health Agency of Canada, updated Mar 2020.

Format
CSV
Access
Table on demand (prepared when opened)
Publisher-reported update
2020-03-02

The Cancer in Young People in Canada (CYP-C) program is a national, population-based surveillance system that collects health and treatment information on each child/youth under the age of fifteen diagnosed with cancer in Canada. These datasets contain the information presented in the tables and figures describing the demographics, diagnosis, treatment, location and timing of care, and outcomes in children diagnosed with cancer from 2001-2006 which were published in the following report: The Public Health Agency of Canada. (2017). Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System. Available online at https://www.canada.ca/en/health-canada/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017.html

Access original file

Data overview

Formats
CSV
File languages
English
Available actions
Explore table (prepared automatically) · Access original file

Sample rows

The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-01.

Cancer typeNew cases, MalesNew cases, FemalesNew cases, TotalM/FASIR (per 1,000,000), MalesASIR (per 1,000,000), FemalesASIR (per 1,000,000), Total
All cancers combined2810232051251.2163141.2152.4
I Leukemias, myeloproliferative diseases, and myelodysplastic diseases89571016101.35343.948.6
I(a) Lymphoid leukemias75055013001.444.234.339.4
I(b) Acute myeloid leukemias10510020515.96.26
I(c) Chronic myeloproliferative diseases1020300.70.60.90.8
I(d) Myelodysplastic syndrome and other myeloproliferative diseases2530550.91.61.91.8
I(e) Unspecified and other specified leukemias1010201.10.60.60.6
II Lymphomas and reticuloendothelial neoplasms4402456851.824.514.219.5
II(a) Hodgkin lymphomas125952201.36.555.8
II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)1306519527.13.75.5

Official sources and licences

Related open data